DUBLIN--(BUSINESS WIRE)--The "Healthcare Contract Research Organization (CRO) Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-Clinical, Clinical), By Service, By Region, And Segment Forecasts, 2019 - 2025" report has been added to ResearchAndMarkets.com's offering.
The global healthcare contract research organization (CRO) market size is expected to reach USD 54.7 billion by 2025, according to this study.
It is anticipated to expand at a CAGR of 6.6% during the forecast period. Increasing cost of drug development is expected to drive the growth. Drug maker and sponsor companies are under pressure to replace the revenue loss caused by generics, increasing patent expirations, number of partnerships to identify biologics, and growing R&D costs, which has made drug development more expensive and complex.
Regulatory framework for drug discovery and drug development is complex in various countries. Thus, an increasing need for expertise in different areas of drug development is driving the demand for outsourcing services. Drug companies are not only outsourcing production of medicines, but also clinical trials. With increasing privatization of clinical trials, there has been an increase in outsourcing of manufacturing processes to developing regions such as India, China, and Latin American countries.
China and India are projected to witness tremendous growth in near future, owing to their treatment nave patient pool coupled with high disease prevalence. Furthermore, genetically diverse population, highly qualified investigators, and well-equipped hospitals are other factors creating growth opportunities in India for global clinical trials market.
In addition, growing pressure on market players to follow stringent timelines has increased the demand for outsourcing of research activities. Even government organizations are outsourcing their clinical trial activities to CROs so that they can carry out the clinical trials with the required infrastructure, expertise, and minimize cost and timelines. In 2015, the Canadian Federal Budget made an investment of USD 1.33 billion for the Canada Foundation for Innovation (CFI).
Key Topics Covered:
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage outlook
3.1.1 Parent market outlook
3.1.2 Related/ancillary market outlook
3.2 Market Segmentation and Scope
3.3 Penetration & Growth Prospects Mapping
3.3.1 Analysis
3.4 Clinical Trials
3.5 User Perspective Analysis
3.5.1 Consumer Behavior Analysis
3.5.2 Market Influencer Analysis
3.6 Regulatory Framework & Reimbursement Scenario
3.7 Market Dynamics
3.7.1 Market Driver Analysis
3.7.1.1 Patent cliff
3.7.1.2 Increasing mergers and collaborations
3.7.1.3 Increasing adoption of advanced technologies
3.7.1.4 Increasing outsourcing of R&D activities
3.7.1.5 Favorable environment for clinical trials in developing countries
3.7.2 Market Restraint Analysis
3.7.2.1 Quality issues of CRO services
3.7.2.2 Intellectual property rights issues
3.8 Business Environment Analysis Tools
3.8.2 Healthcare CRO Market - PESTLE Analysis
Chapter 4 Healthcare CRO Market: Type Estimates & Trend Analysis
4.1 Healthcare CRO Type Market Share Analysis, 2018 & 2025
4.2 Healthcare CRO Type Market Segment Dashboard
4.3 Market Size & Forecasts and Trend Analyses, 2014 to 2025 for the Type Segment
4.3.1 Drug Discovery
4.3.1.1 Drug discovery market, 2014 - 2025 (USD Million)
4.3.1.2 Target validation
4.3.1.3 Lead identification
4.3.1.4 Lead optimization
4.3.2 Preclinical
4.3.3 Clinical
Chapter 5 Healthcare CRO Market: Service Estimates & Trend Analysis
5.1 Healthcare CRO Service Market Share Analysis, 2018 & 2025
5.2 Healthcare CRO Service Market Segment Dashboard
5.3 Competitive Landscape- Qualitative Analysis by Services
5.4 Market Size & Forecasts and Trend Analyses, 2014 to 2025 for the Service
5.4.1 Project Management/Clinical Supply Management
5.4.2 Data Management
5.4.3 Regulatory/Medical Affairs Outsourcing
5.4.4 Medical Writing
5.4.5 Clinical Monitoring
5.4.6 Quality Management/ Assurance
5.4.7 Biostatistics
5.4.8 Investigator Payments
5.4.9 Laboratory
5.4.10 Patient and Site Recruitment
5.4.11 Technology
5.4.12 Others
Chapter 6 Healthcare CRO Market: Regional Estimates & Trend Analysis, by Type and Service
6.1 Healthcare CRO Regional Market Share, 2018 & 2025
6.2 Healthcare CRO Regional Market: Segment Dashboard
6.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
6.4 List of Players at Regional Level
Chapter 7 Competitive Landscape
7.1 Recent Developments & Impact Analysis, by Key Market Participants
7.2 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
7.3 Vendor Landscape
7.4 Strategy Mapping
7.5 Public Companies
7.6 Private Companies
7.7 Healthcare Contract Research Organization (CRO) Market Share, 2018
7.8 Healthcare CRO Market: Qualitative Analysis of Models
7.9 Company Profiles
- IQVIA
- Covance Inc.
- Pharmaceutical Product Development, LLC (PPD)
- PAREXEL
- Charles River Laboratories
- ICON, Plc
- Medidata Solutions, Inc.
- Syneos Health
- Theorem Clinical Research
- Pharmaron
- GVK Biosciences Private Limited
- Dishman Carbogen Amics Limited
For more information about this report visit https://www.researchandmarkets.com/r/prt9cs
